Tony Serafini-Lamanna - Nov 15, 2021 Form 4 Insider Report for MERIDIAN BIOSCIENCE INC (VIVO)

Role
Executive VP-Diagnostics
Signature
/s/ Bryan T. Baldasare as Attorney-in-fact for Tony Serafini-Lamanna
Stock symbol
VIVO
Transactions as of
Nov 15, 2021
Transactions value $
$0
Form type
4
Date filed
11/16/2021, 02:59 PM
Previous filing
Nov 8, 2021
Next filing
Oct 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIVO Common Stock Other -24.3K -57.36% 18.1K Nov 15, 2021 Direct F1
transaction VIVO Common Stock Award +24.3K +134.54% 42.4K Nov 15, 2021 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted share units granted pursuant to 2012 Stock Incentive Plan rescinded by the Issuer.
F2 Restricted share units granted pursuant to 2021 Omnibus Award Plan scheduled to vest as follows: (i) 1,200 on September 16, 2022; (ii) 12,320 on November 15, 2022; and (iii) 10,823 on November 15, 2023.